Halovate-S Ointment is a topical formulation combining Halobetasol propionate 0.05% w/w, a potent corticosteroid, with Salicylic Acid 3% w/w, a keratolytic agent, designed for the treatment of various inflammatory and hyperkeratotic dermatological conditions. Halobetasol exerts strong anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses within the skin. Salicylic Acid facilitates the removal of scales and promotes exfoliation by softening and loosening keratin, thereby enhancing the penetration and efficacy of the corticosteroid. Halovate-S Ointment is indicated for the management of chronic plaque psoriasis, lichen planus, eczema, and other hyperkeratotic dermatoses where inflammation and scaling are prominent. The ointment base provides occlusive properties that improve drug absorption and skin hydration. It should be applied sparingly to the affected areas once or twice daily as directed by a healthcare professional, avoiding prolonged use to minimize the risk of corticosteroid-related adverse effects such as skin atrophy, telangiectasia, and systemic absorption. Caution is advised in patients with infections or hypersensitivity to any components. Halovate-S Ointment offers an effective therapeutic option combining anti-inflammatory and keratolytic actions for improved clinical outcomes in resistant dermatological disorders.